Resection of Locally Advanced Pancreatic Cancer after Downstaging with Continuous-Infusion 5-Fluorouracil, Mitomycin-C, Leucovorin, and Dipyridamole

Journal of Gastrointestinal Surgery

Volumn 2, Issue 2, 1998, Pages 159-166

  Todd, Karen E ^a   Gloor, Beat ^a   Lane, John S ^a   Isacoff, William H ^a   Reber, Howard A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDOTE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC ANTIMETABOLITE; DIPYRIDAMOLE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN; PHOSPHODIESTERASE INHIBITOR;

ADULT; AGED; ARTICLE; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PANCREAS RESECTION; PANCREAS TUMOR; PATHOLOGY; PROSPECTIVE STUDY; REMISSION; SURVIVAL RATE;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTIDOTES; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DIPYRIDAMOLE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; LEUCOVORIN; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PHOSPHODIESTERASE INHIBITORS; PROSPECTIVE STUDIES; REMISSION INDUCTION; SURVIVAL RATE;

EID: 0032009833     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(98)80008-5     Document Type: Article

References (19)

1. Gold EB. Epidemiology of and risk factors for pancreatic cancer. Surg Clin North Am 1995;75:819-843.
2. Moertel CG, Childs DS, Reitemeier RJ, Colby MY, Holbrook MA. Combined 5-FU and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;2: 865-867.
3. Gastrointestinal Tumor Study Group. Moertel CG, Frytak S, Hahn RG, O'Connell MJ, Reitemeier RJ, Rubin J, Schutt AJ, Weiland LH, Childs DS, Holbrook MA. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6,000 rads) radiation alone, moderate dose radiation (4,000 rads) plus 5-fluorouracil, and high dose radiation plus 5-fluorouracil. Cancer 1981;48:1705-1710.
4. Grem JL, Hoth DF, Hamilton JM, King SA, Leyland-Jones B. Overview of current status and future direction of clinical trial with 5-fluorouracil in combination with folinic acid. Cancer Treat Rep 1987;71:1249-1264.
5. Advanced Colorectal Cancer Meta-analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 1992;10:896-903.
6. DeCaprio JA, Mayer RJ, Gonin R, Arbuc SG. Fluorouracil and high dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: Results of a phase H trial. J Clin Oncol 1991;9:2128-2133.
7. Isacoff WH, Eilber FR, Kuckenbecker SL, Jacobs AD, Taylor O. Continuous infusion 5-fluorouracil given with calcium leucovorin, dipyridamole, and mitomycin-C in patients with advanced colorectal carcinoma: A phase II trial. J Infusional Chemotherapy 1994;10:107-111.
8. MacMillan WE, Woberg WH, Welling PG. Pharmacokinetics of 5-fluorouracil in humans. Cancer Res 1978;38:3479-3482.
9. Lokich JJ, Ahlgren JD, Gullo JJ, Philips JA, Fryer JG. A prospective randomized comparison of continuous infusion fluorouracil with conventional bolus schedule in metastatic colorectal carcinoma: A Mid-Atlantic Oncology Program Study. J Clin Oncol 1989;7:425-432.
10. Chabner BA. Pyrimidine antagonists. In Chabner BA, ed. Pharmacologic Principles of Cancer Treatment. Philadelphia: WB Saunders, 1982, pp 183-212.
11. Santi DV, McHenry C, Sommer H. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry 1978;17:4018-4024.
12. Evans MR, Laskin JD, Hakala MT. Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. Cancer Res 1981;41:3288-3295.
13. Breitman TR. The feedback inhibition of thymidine kinase. Biochim Biophys Acta 1963;67:153-158.
14. Ives DH, Morse PA, Potter VR. Feedback inhibition of thymidine kinase by thymidine triphosphate. J Biol Chem 1963;238:1467-1474.
15. Van Mouwerik TJ, Pangallo CA, Willson JK, Fischer PH. Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole. Biochem Pharmacol 1987;36:809-814.
16. Grem JL. Biochemical modulation of fluorouracil by dipyridamole: Principal and clinical experience. Semin Oncol 1992;19:56-65.
17. Rusello O, Romanini A, Sivallen D, Rosso R, Nicolin A, Sobrero A. Time-dependent interaction between 5-FU and mitomycin-C on a human colon carcinoma cell line, HCP-8, in vitro. Eur J Cancer Clin Oncol 1989;25:571-572.
18. Pilepich MV, Miller HH. Preoperative irradiation in carcinoma of the pancreas. Cancer 1980;46:1945-1949.
19. Yeung RS, Weese JL, Hoffman JP, Solin LJ, Paul AR, Engstrom PF, Litwin S, Kowalyshyn MJ, Eisenberg BL. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study. Cancer 1993;72:2124-2133.